REGULATORY

• LDP Lawmakers Air Concerns over MOF Push for Negative Fee Revision
  November 8, 2023

• Abecma Clears Japan Panel Review for 3rd Line MM Use
  November 7, 2023

• Health Minister to Make Direct Request to 24 Makers for Supply Ramp-Up
  November 7, 2023

• Japan PM Advisor Pushes Rethink of LLP Coverage to Reward Innovation, Pricing Debate without Taboos
  November 6, 2023

• Japan OKs New Economic Package; Startup, Pharma Promotion Embraced
  November 6, 2023

• FPMAJ Renews Call for Premium for Drugs Launched in Japan without Delay: LDP Confab
  November 6, 2023

• Reward Innovation by Revisiting LLP Copay, Cut Doctor Fees: MOF
  November 2, 2023

• Japan PM Pins Hope for Leadership of Kamoshita as Drug Policy Advisor
  November 2, 2023

• MHLW to Consider Investigation on OTC Drug Abuse: Minister
  November 2, 2023

• Organization to Push Drug Discovery Is One Option: Health Minister
  November 1, 2023

• Basic Dementia Law Set to Take Effect on January 1: MHLW
  November 1, 2023

• Japan Economic Package to Call for Boosting Innovation for Next-Gen Biologics
  November 1, 2023

• Cases of Unintentional Xocova Use in Pregnant Women Total 32: MHLW
  October 31, 2023

• AMED, Europe’s HERA to Cooperate in Medical Countermeasures
  October 31, 2023

• PMDA Investigating Safety Risks of Eliquis, Other Anticoagulants for Acute Kidney Injury
  October 30, 2023

• No Objections to Reflecting Company Indices for Generic Supplies in Pricing: Chuikyo
  October 30, 2023

• Medical, Long-Term Care Data Linkage Holds Key to CEA: Leqembi Debate
  October 30, 2023

• Panel OKs Xarelto’s Label Expansion for Post-Fontan Heart Failure Patients
  October 30, 2023

• Lawmakers Demand NIP Coverage for Male Use of 4-Valent HPV Vaccine
  October 26, 2023

• Japan’s Healthcare Spending Hits 45 Trillion Yen in FY2021
  October 26, 2023

ページ

• « 先頭
• ‹ Prev
• …
• 73
• 74
• 75
• 76
• 77
• 78
• 79
• 80
• 81
• …
• Next ›
• 最終 »